Showing results (101-110 of 397) with videos related to

Sort By:
Pageof 40
European Journal of Heart Failure|November 4, 2009
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008Dirk J van Veldhuisen, Alexander H Maass, Silvia G Priori, et al.
European Journal of Heart Failure|January 10, 2018
Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database InitiativeJoão Pedro Ferreira, Kevin Duarte, Marc A Pfeffer, et al.
The New England Journal of Medicine|February 17, 2005
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma preventionScott D Solomon, John J V McMurray, Marc A Pfeffer, et al.
The New England Journal of Medicine|November 22, 2014
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitorsMatthew R Weir, George L Bakris, David A Bushinsky, et al.
European Journal of Heart Failure|October 31, 2015
What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day InitiativeStefan Störk, Ausra Kavoliuniene, Dragos Vinereanu, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2017
Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database InitiativeStefano Coiro, Nicolas Girerd, Patrick Rossignol, et al.
European Journal of Heart Failure|October 25, 2016
Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database InitiativeStefano Coiro, Nicolas Girerd, Patrick Rossignol, et al.
Chinese Medical Journal|October 31, 2012
A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatmentDa-Yi Hu, Jun Huang, Nai-Sheng Cai, et al.
Plos One|January 4, 2013
Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarctionJørgen Gravning, Stein Ørn, Ole Jørgen Kaasbøll, et al.
The American Journal of Cardiology|April 11, 2018
Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative)Zied Frikha, João Pedro Ferreira, Erwan Bozec, et al.
Pageof 40